BEDINI, ANNALIDA
 Distribuzione geografica
Continente #
NA - Nord America 12.135
EU - Europa 8.640
AS - Asia 4.076
SA - Sud America 340
AF - Africa 68
Continente sconosciuto - Info sul continente non disponibili 22
OC - Oceania 11
AN - Antartide 1
Totale 25.293
Nazione #
US - Stati Uniti d'America 11.992
GB - Regno Unito 2.133
CN - Cina 2.047
NL - Olanda 1.971
IT - Italia 1.097
SG - Singapore 1.089
UA - Ucraina 896
SE - Svezia 529
RU - Federazione Russa 507
FI - Finlandia 428
DE - Germania 407
TR - Turchia 370
BR - Brasile 249
FR - Francia 217
IE - Irlanda 192
VN - Vietnam 172
IN - India 104
CA - Canada 101
HK - Hong Kong 54
BE - Belgio 46
PL - Polonia 38
ES - Italia 37
AR - Argentina 35
BD - Bangladesh 35
JP - Giappone 32
KR - Corea 31
AT - Austria 23
MX - Messico 23
RO - Romania 22
IQ - Iraq 19
EU - Europa 18
ID - Indonesia 18
EG - Egitto 16
ZA - Sudafrica 16
KE - Kenya 15
AE - Emirati Arabi Uniti 12
AL - Albania 12
PK - Pakistan 12
CH - Svizzera 11
LT - Lituania 11
PT - Portogallo 11
SA - Arabia Saudita 11
CO - Colombia 10
CL - Cile 9
PE - Perù 9
AU - Australia 8
EC - Ecuador 7
IL - Israele 7
KZ - Kazakistan 7
PY - Paraguay 7
UZ - Uzbekistan 7
VE - Venezuela 7
DK - Danimarca 6
GR - Grecia 6
IR - Iran 6
MA - Marocco 6
PH - Filippine 6
EE - Estonia 5
JM - Giamaica 5
MY - Malesia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AZ - Azerbaigian 4
CZ - Repubblica Ceca 4
JO - Giordania 4
NP - Nepal 4
SI - Slovenia 4
TG - Togo 4
AM - Armenia 3
BG - Bulgaria 3
BZ - Belize 3
HN - Honduras 3
HU - Ungheria 3
LU - Lussemburgo 3
MD - Moldavia 3
OM - Oman 3
SK - Slovacchia (Repubblica Slovacca) 3
TW - Taiwan 3
UY - Uruguay 3
AO - Angola 2
BB - Barbados 2
BO - Bolivia 2
BY - Bielorussia 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
GU - Guam 2
IS - Islanda 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
RS - Serbia 2
SM - San Marino 2
TH - Thailandia 2
TN - Tunisia 2
BF - Burkina Faso 1
CI - Costa d'Avorio 1
DZ - Algeria 1
ET - Etiopia 1
FK - Isole Falkland (Malvinas) 1
GA - Gabon 1
GE - Georgia 1
GS - Georgia del Sud e Isole Sandwich Australi 1
Totale 25.279
Città #
Amsterdam 1.944
Southend 1.893
Dallas 1.200
Woodbridge 1.169
Fairfield 968
Ashburn 931
Houston 761
Jacksonville 710
Ann Arbor 681
Chandler 588
Singapore 548
San Jose 536
Cambridge 446
Wilmington 394
Seattle 382
Nanjing 352
Beijing 318
Urbino 275
Izmir 258
Boardman 223
Helsinki 194
Dublin 188
Los Angeles 179
New York 158
Chicago 155
Nanchang 153
Council Bluffs 130
San Mateo 113
Princeton 106
Lauterbourg 101
Düsseldorf 86
Shenyang 83
Munich 81
Hebei 78
Changsha 77
Tianjin 76
Salt Lake City 69
Des Moines 66
Ho Chi Minh City 65
Istanbul 65
Jiaxing 56
Santa Clara 51
Hong Kong 46
Brussels 45
Kunming 43
London 42
Moscow 42
Shanghai 41
Elk Grove Village 39
Tampa 39
Jinan 38
Velikiy Novgorod 38
Hanoi 37
Toronto 37
Buffalo 36
San Francisco 36
Turku 36
Bremen 35
Guangzhou 35
Hangzhou 35
Orem 33
Nuremberg 32
Venice 31
Frankfurt am Main 30
Warsaw 30
San Diego 28
São Paulo 27
Montreal 26
Rome 26
Seongnam 24
Zhengzhou 24
Chennai 23
Ningbo 22
Stockholm 22
Bellaria-Igea Marina 21
Mülheim 20
Tokyo 20
Haikou 19
Milan 19
Sterling 19
Denver 18
Dulles 18
Phoenix 18
Wuppertal 18
Changchun 17
Lancaster 17
Manchester 17
Tavullia 17
The Dalles 16
Bologna 15
Brooklyn 15
Parma 15
Boston 14
Lanzhou 14
Poplar 14
Augusta 13
Miami 13
Norwalk 13
Atlanta 12
Johannesburg 12
Totale 18.409
Nome #
1-Aminocyclopropane-1-carboxylic acid derivatives as ligands at the glicine-site of the NMDA receptor. 3.185
Industrial and academic approaches to the search for alternative melatonin receptor ligands: An historical survey. 709
1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID DERIVATIVES AS LIGANDS AT THE GLYCINE-BINDING SITE OF THE N-METHYL-D-ASPARTATE RECEPTOR 433
Iridium-Catalyzed Direct Synthesis of Tryptamine Derivatives from Indoles: Exploiting N-Protected β-Amino Alcohols as Alkylating Agents 391
1-Aminocyclopropane-1-carboxylic acid derivatives: Synthesis and NMDA receptor complex binding affinity study. 336
Therapeutic uses of melatonin and melatonin derivatives: a patent review (2012-2014) 332
1-Amminocyclopropane-1-Carboxylic Acid Derivatives: A New, General Synthesis and NMDA Receptor Complex Binding Affiniy Study 330
An improved synthesis of cis-4-phenyl-2-propionamidotetralin (4-P-PDOT): a selective MT2 melatonin receptor antagonist. 327
Towards the development of 5-HT7 ligands combining serotonin-like and arylpiperazine moieties 311
Synthesis and Configuration Determination of All Enantiopure Stereoisomers of the Melatonin Receptor Ligand 4-Phenyl-2-propionamidotetralin using an Expedient Optical Resolution of 4-Phenyl-2-tetralone 303
Synthesis of Tryptamine Derivatives via a Direct, One-Pot Reductive Alkylation of Indoles 300
Design, synthesis and biological activity of hydrogen peroxide responsive arylboronate melatonin hybrids 297
3-(2-Carbamoylvinyl)-4,5-dimethylpyrrole-2-carboxylic acids as ligands at the NMDA glycine-binding site: a study on the 2-carbamoylvinyl chain modification 283
(E)-3-(2-(N-phenylcarbamoyl)vinyl)pyrrole-2-carboxylic acid derivatives. A novel class of glycine site antagonists. 281
Tricyclic Alkylamides as Melatonin Receptor Ligands with Antagonist or Inverse Agonist Activity 277
Highly Potent and Selective MT2 Melatonin Receptor Full Agonists from Conformational Analysis of 1-Benzyl-2-acylaminomethyl-tetrahydroquinolines 277
Synthesis and Characterization of New Bivalent Agents as Melatonin- and Histamine H3-Ligands 276
Antidepressant-like activity and cardioprotective effects of fatty acid amide hydrolase inhibitor URB694 in socially stressed Wistar Kyoto rats 274
Synthesis and Biological Activity of new melatonin dimeric derivatives. 273
4,5-Dihydroisoxazole and 4,5-dihydro-1,2,4-oxadiazole derivatives from cycloaddition reactions of nitrile oxides to alkyl N-(diphenylmethylene)-α ,β -dehydroamino acids 273
Tetrahydroquinoline Ring as a Versatile Bioisostere of Tetralin for Melatonin Receptor Ligands 273
An improved route to cycloalka[b]pyrrole 2-carboxylates 269
Selective Melatonin MT2 receptor ligands relieve neuropathic pain through modulation of brainstem descending antinociceptive pathways 269
Direct, One-Pot Reductive Alkylation of Anilines with Functionalized Acetals Mediated by Triethylsilane and TFA. Straightforward Route for Unsymmetrically Substituted Ethylenediamine 267
Identification of Bivalent Ligands with Melatonin Receptor Agonist and Fatty Acid Amide Hydrolase (FAAH) Inhibitory Activity That Exhibit Ocular Hypotensive Effect in the Rabbit 260
2-[N-Acylamino(C1-C3)alkyl]indoles as MT1 melatonin receptor partial agonists, antagonists, and putative inverse agonists 247
Application of a non-electrophysiological method to study binding affinity and efficacy of glicine analogs to the glicine site of the NMDA receptor-ion channel complex. 241
2-Arylmelatonin analogues: Probing the 2-phenyl binding pocket of melatonin MT1 and MT2 receptors 236
2,3-Dehydroamino acid derivatives as intermediates in the synthesis of heterocyclic compounds. 233
N-(Substituted-anilinoethyl)acylamides: Design, Synthesis and Pharmacological Characterization of a New Class of Melatonin Receptor Ligands 230
The rationale for the development of melatonin receptor ligands 226
Bivalent Ligand Approach on N-[2-[(3-methoxyphenyl)methylamino]ethyl]acetamide. Synthesis, Binding Affinity and Intrinsic Acivity for MT(1) and MT(2) melatonin Receptors. 225
Diastereo- and enantioselective hydrogenation of a challenging enamide derived from 4-phenyl-2-tetralone: an appealing shortcut towards enantiopure cis-2-aminotetraline derivatives 225
Melatonin MT1 and MT2 Receptors Exhibit Distinct Effects in the Modulation of Body Temperature across the Light/Dark Cycle 223
Design and synthesis of N-[3,3-diphenyl-propenyl]alkanamides as a novel class of potent MT2-selective Melatonin receptor ligands 221
(E)-3-[2-(Carbamoylvinyl)]pyrrol-2-carboxylic acid derivatives: A novel Class of glycine site Antagonists. 221
N-(Anilinoethyl)amides: design and synthesis of metabolically stable, selective melatonin receptor ligands. 220
Synthetic Melatonin Receptor Ligands 220
Pharmacokinetic and pharmacodynamic evaluation of ramelteon : an insomnia therapy 218
Toward the Definition of Stereochemical Requirements for MT(2)-Selective Antagonists and Partial Agonists by Studying 4-Phenyl-2-propionamidotetralin Derivatives 217
Cardioprotective effects of fatty acid amide hydrolase inhibitor URB694, in a rodent model of trait anxiety 215
Differentiation between isomeric 1-aminocyclopropane-1-carboxylic acid derivatives by means of chemical ionisation and mass selected collision induced dissociation 214
N-acetiltriptamine 2,5-sostituite: sintesi e valutazione dell’attività biologica per i recettori melatoninergici MT1 e MT2 214
N-Acyl-5- and -2,5-substituted tryptamines: synthesis, activity and affinity for human mt1 and MT2 melatonin receptors 213
Synthesis, Enantiomeric Resolution and Structure-Activity Relationship Study for a Series of 10,11-Dihydro-5H-dibenzo[a,d]cycloheptene MT2 Receptor Antagonists. 212
Promotion of non-rapid eye movement sleep and activation of reticular thalamic neurons by a novel MT2 melatonin receptor ligand 210
Antiproliferative and pro-apoptotic activity of melatonin analogues on melanoma and breast cancer cells 208
Plant-derived phenolic compounds prevent the DNA single-strand breakage and cytotoxicity induced by tert-butylhydroperoxide via an iron-chelating mechanism. 207
Homology models of melatonin receptors: challenges and recent advances 204
MELATONIN RECEPTOR AGONISTS: SAR AND APPLICATIONS TO THE TREATMENT OF SLEEP-WAKE DISORDERS 202
SYNTHESIS, BINDING AFFINITY FOR THE MELATONIN RECEPTOR, AND EVALUATION OF THE BIOLOGICAL ACTIVITY OF NEW INDOLE-BASED MELATONIN ANALOGUES. 200
Alchilammidi tricicliche: legandi selettivi dei recettori melatoninergici MT1 e MT2 199
Substituent effects on 1,3-dipolar cycloadditions to some 1,1-diphenyl-2-aza-1,3-butadiene derivatives 191
Anxiolytic effects of the melatonin MT2 receptor partial agonist UCM765: Comparison with melatonin and diazepam 189
Application of 3D-QSAR in the Rational Design of Receptor Ligands and Enzyme Inhibitors 188
A novel melatonin partial agonist with sleep-promoting properties 187
THREE-DIMENSIONAL QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP STUDIES ON SELECTED MT1 AND MT2 MELATONIN RECEPTOR LIGANDS: REQUIREMENTS FOR SUBTYPE SELECTIVITY AND INTRINSIC ACTIVITY MODULATION 184
Strategies leading to MT2 selective melatonin receptor antagonists 184
Synthesis and conformational study of 3,4-carbocyclic bridged indole melatonin and serotonin analogues 183
ANTIMETASTATIC ACTION OF A NEW ANALOG OF DACARBAZINE IN MICE BEARING LEWIS LUNG CARCINOMA 180
Reactions of 3-Carbomethoxy-2-aza-1,3-Butadiene Derivatives with Dienophiles 179
Recent advances in the development of melatonin MT1 and MT2 receptor agonists 178
Synthesis and biological evaluation of 6-bromo-6-substituted penicillanic acid derivatives as beta-lactamase inhibitors. 177
2-5-Disubstituted tryptamines a selective serotonin 5HT6 receptor agonists. 177
Progettazione e Sintesi di nuovi ligandi dei recettori MT1 e MT2 della melatonina a struttura difenilalchilammidica. 176
Strategies leading to MT2 selective melatonin receptor antagonists 175
Melatonin receptor agonists: new options for insomnia and depression treatment 173
Synthesis, antioxidant activity and structure-activity relationships for a new series of 2-(N-acylaminoethyl)indoles with melatonin-like cytoprotective activity 172
Melatonin, non-selective MT1/MT2 and selective MT2 receptor agonists: differential effects on the 24-hr vigilance states 172
Antioxidant and cytoprotective effect of indole derivatives related to melatonin 168
Short synthesis of tryptophan and β -carboline derivatives by reaction of indoles with N-(diphenylmethylene)-α ,β -didehydroamino acid esters 167
Antioxidant and cytoprotective activity of indole derivatives related to melatonin, 166
Analysis of structure-activity relationships for MT2 selective antagonists by melatonin MT1 and MT2 receptor models 166
Synthesis, Pharmacological Characterization and QSAR Studies on 2-Substituted Indole Melatonin Receptor Ligands 162
A novel melatonin partial agonist with sleep promoting properties and anti-anxiety effects. 161
A novel melatonin partial agonist with sleep-promoting properties. 158
Indole-based analogs of melatonin: in vitro antioxidant and cytoprotective activities 158
N-(anilinoethyl)acylamides: new melatonin receptor ligands with sleep inducing properties. 158
MT2 selective melatonin receptor antagonists. Design and structure activity relationships 157
N-(Anilinoethyl)amide Melatonergic Ligands with Improved Water Solubility and Metabolic Stability 156
Synthesis of new 6-bromopenicillanic acid derivatives as potential β-lactamase inhibitors. 151
MT1-Selective Melatonin Receptor Ligands: Synthesis, Pharmacological Evaluation, and Molecular Dynamics Investigation of N-{[(3-O-Substituted)anilino]alkyl}amides 144
Synthesis of new C-6 alkylidene penicillin derivatives as beta-lactamase inhibitors 144
MT2 selective melatonin receptor antagonists: design and structure-activity relationships 142
Towards the development of mixed MT1-agonist/MT2-antagonist melatonin receptor ligands 142
Correlation of the antimetastatic properties of aryltriazenes with their Electron Impact Ionization Mass Spectronomy 140
Selective increase of Slow Wave Sleep (SWS) by a novel melatonin partial agonist 135
Synthesis, binding and QSAR studies of new 2-substituted melatonergic agonists. 133
Rapid and transient stimulation of intracellular reactive oxygen species by melatonin in normal tumor leukocytes, Toxicology and apllied Pharmacology, 239(1), 37-45 (2009) 132
In vitro metabolism of the melatonin MT2-receptor selective ligand UCM765 by rat, mouse and human liver substrates 132
Chiral Recognition of Flexible Melatonin Receptor Ligands Induced by Conformational Equilibria 132
Binding and unbinding of potent melatonin receptor ligands: Mechanistic simulations and experimental evidence 131
Analoghi della melatonina: effetto dei sostituenti sull’attività di derivati N-acetiltriptaminici. 131
Novel melatonin ligands having antidepressant activity as well as sleep inducine properties 129
INVESTIGATION OF SOME 2,3-DIDEHYDRO AMINOACIFS BY FAST ATOM BOMBARDMENT, CHEMICAL IONIZATION AND MASS-SELECTED COLLISION-INDUCED DISSOCIATION MASS SPECTROMETRY. 129
Chemical modification of NSC12 leads to a specific FGF-trap with antitumor activity in multiple myeloma 128
Selective increase of Slow Wave Sleep (SWS) by melatonin 2 receptors. 124
Synthesis of new 6-alkyliden penicillin derivatives as potential beta-lactamase inhibitors. 124
Advances on the Development of Subtype Selective Melatonin Ligands 123
In vitro evaluation of antioxidant activity for a series of 2-acylaminoethylindoles, PBA2004 117
Totale 24.212
Categoria #
all - tutte 81.574
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.574


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021119 0 0 0 0 0 0 0 0 0 0 0 119
2021/20221.284 128 145 125 165 23 35 57 62 86 72 31 355
2022/20231.850 209 122 56 207 163 405 7 165 296 56 122 42
2023/2024565 32 58 28 77 40 100 32 13 67 57 18 43
2024/20252.718 136 105 428 110 67 162 277 109 167 159 247 751
2025/20267.457 433 657 1.177 772 384 384 618 168 2.151 378 248 87
Totale 25.551